The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary data of a phase Ib/II trial evaluating the efficacy and safety of adebrelimab, camrelizumab plus apatinib as first-line therapy in patients with advanced hepatocellular carcinoma.
 
Yin Long
No Relationships to Disclose
 
Qiong Yang
No Relationships to Disclose
 
Ziqi Huang
No Relationships to Disclose
 
Xiaodong He
No Relationships to Disclose
 
Jue Huang
No Relationships to Disclose
 
Jianguo Liao
No Relationships to Disclose
 
Yajin Chen
No Relationships to Disclose
 
Hai Hu
No Relationships to Disclose
 
Lei Zhang
No Relationships to Disclose